Global site English

NYSE: TRIO 61.84 down −0.47 (−0.75%) Close 2 Nov 2026

Information for investors

On 19 October 2026 the Turing Registry revoked the licenses of two systems operated by TriOptimum at Citadel Station and aboard the research vessel Von Braun. The company intends to appeal. Read the company’s statement and the related Form 8-K of 20 October 2026. Third-quarter results have been rescheduled to 12 November 2026.

Share price, results and events

NYSE: TRIO USD

61.84

down −0.47 (−0.75%)

Close, 2 November 2026, 4:00 p.m. EST. Delayed data, for information only.

TriOptimum share price, last twelve months (NYSE: TRIO, USD) Line chart of TriOptimum's daily closing share price from 3 Nov 2025 to 2 Nov 2026. The price rose from 71.40 dollars to a high of 85.11 on 6 Aug 2026, fell sharply in the week of 19 October 2026 to a low of 57.10 on 21 Oct 2026, and closed at 61.84. 50.00 60.00 70.00 80.00 90.00 DecJan 26FebMarAprMayJunJulAugSepOctNov
52-week high 85.11 52-week low 57.10 12-month change -13.4%

Latest results

Second quarter 2026

Published 29 July 2026

All results and presentations

Events and key dates

Revenue, 20251
$41.27bn
Segment margin, 20252
12.1%
Adjusted EPS, 20252
$4.88
Free cash flow, 20252
$4.61bn
Annual dividend per share3
$2.08
  1. Year ended 31 December 2025, as reported.
  2. Adjusted segment margin, adjusted earnings per share and free cash flow are non-GAAP measures. Reconciliations to the nearest GAAP measures are included in the results release.
  3. Four quarterly payments of $0.52. Dividend declarations are at the discretion of the Board.
Revenue and adjusted segment margin by segment, years ended 31 December. US dollars in millions.
SegmentRevenue 2025Revenue 2024ChangeSegment margin 2025
Security Products9,8409,512+3.4%15.2%
Medical Systems8,1207,604+6.8%13.9%
Orbital & Research Systems7,0607,131−1.0%8.7%
Resources & Materials6,4806,551−1.1%9.4%
Network Services6,3105,688+10.9%14.6%
Agrisystems3,4603,172+9.1%7.8%
TriOptimum41,27039,658+4.1%12.1%

Segment margin is a non-GAAP measure. Corporate costs and eliminations are allocated to segments. Orbital & Research Systems includes the operation of Citadel Station and the research vessel Von Braun.

Recent filings with the US Securities and Exchange Commission
DateFormDescriptionAccession no.
2026-11-028-KChange in date of third-quarter results release0000921140-26-000188
2026-10-278-KAppointment of officer; formation of Board committee0000921140-26-000181
2026-10-228-KDeparture of officer (Item 5.02)0000921140-26-000176
2026-10-208-KRegulation FD disclosure: Turing Registry decision of 19 October 2026; postponement of third-quarter results release from 28 October, new date to be announced (Items 7.01, 8.01)0000921140-26-000172
2026-07-2910-QQuarterly report for the period ended 30 June 20260000921140-26-000131
2026-05-158-KResults of the Annual Meeting of Shareholders0000921140-26-000097
Credit ratings of TriOptimum Corporation
AgencyLong-termOutlook
S&P Global RatingsUpdated 2026-10-20A- / A-2CreditWatch negative
Moody’sUpdated 2026-10-22A3 / P-2Negative (from stable)
Fitch RatingsUpdated 2026-03-11A- / F2Stable

Ratings are the opinions of the agencies, are not recommendations to buy, sell or hold securities, and may be changed or withdrawn at any time.

Investor Relations

Oliver Pike, Vice President, Investor Relations
investors@trioptimumcorp.com
+1 212 103 4400

Registered shareholders

Harrowgate Shareholder Services, Transfer Agent
+1 800 105 6219 (toll-free in the US and Canada)
+1 201 107 4492 (elsewhere)

Bondholders

Group Treasury, Halsworth Park
treasury@trioptimumcorp.com
+44 113 496 0348

Email alerts

Releases, filings and event reminders are published in the newsroom feed. Email alerts are being moved to a new provider and are unavailable until further notice.